Prosecution Insights
Last updated: November 04, 2026

NuLiv Science USA, Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

NuLiv Science USA, Inc. manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action for the company. This action is assigned to 1 distinct examiner and 1 distinct art unit, reflecting a very focused prosecution environment. Such a concentration suggests that the company's intellectual property strategy is currently centered on a specific technical niche within the broader Biotechnology & Pharmaceuticals field.

The busiest examiner for this portfolio is HOFFMAN, SUSAN COE, who is managing 1 pending office action. Because the company has only 1 pending office action, HOFFMAN, SUSAN COE is responsible for the 1 pending office action currently active. The outcome of this biotechnology portfolio is currently subject to the specific examination standards of this 1 distinct examiner. For a practitioner, this implies that understanding the historical allowance rates and preferences of HOFFMAN, SUSAN COE is critical for predicting the success of the 1 pending office action.

The presence of only the 1 distinct art unit further reinforces the specialized nature of the company's current filings. With the pending office action as the only active matter, the company's immediate legal focus is streamlined. This lack of diversity in examiners and art units simplifies the management of the portfolio but also increases the impact of any single decision made by the assigned examiner within the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOFFMAN, SUSAN COE 1 54.2% +25.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18239287 COMPOSITION OF BOTANICAL EXTRACTS FOR SLEEP AND MOOD SUPPORT HOFFMAN, SUSAN COE 77d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18239287 COMPOSITION OF BOTANICAL EXTRACTS FOR SLEEP AND MOOD SUPPORT HOFFMAN, SUSAN COE 77d overdue

Top Art Units

Art UnitApps
1655 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18239287 COMPOSITION OF BOTANICAL EXTRACTS FOR SLEEP AND MOOD SUPPORT HOFFMAN, SUSAN COE 1655 §101§102§103§112 Non-Final OA 77d overdue Pending Aug 29, 2023

Managing NuLiv Science USA, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does NuLiv Science USA, Inc. have?

NuLiv Science USA, Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most NuLiv Science USA, Inc. applications?

Susan Coe Hoffman has the most, with 1 of NuLiv Science USA, Inc.'s pending office actions.

What technology area are NuLiv Science USA, Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month